Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATACAS Trial
NL-OMON40015Active, not recruiting
- Sponsor
- The Alfred Hospital
- Start
- Jun 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of aspirin and tranexamic acid in coronary arteriosclerosis (4 arms), sponsored by The Alfred Hospital. Primary endpoint: Composite of 30-day mortality or major morbidity. Started Jun 2014; status: active, not recruiting.
02
Drugs
aspirintranexamic acid
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on NL-OMON40015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40015.